# Evaluating miscarriage incidence after COVID-19 vaccination

**Authors:** Fariba Shahraki-Sanavi, Sajad Sahab-Negah, Sairan Nili, Parvin Mangolian shahrbabaki, Alireza Ansari-moghaddam, Mohammad Fereidouni, Abtin Heidarzadeh, Mostafa Enayatrad, Sepideh Mahdavi, Roqayeh Aliyari, Mansooreh Fateh, Hamidreza Khajeha, Zahra Emamian, Elahe Behmanesh, Hossein Sheibani, Maryam Abbaszadeh, Reza Jafari, Maryam Valikhani, Ehsan Binesh, Hamid Vahedi, Sahar Shabestari, Reza Chaman, Hamid Sharifi, Mohammad Hassan Emamian

PMC · DOI: 10.1038/s41598-025-06904-y · 2025-07-01

## TL;DR

This study found that receiving a COVID-19 vaccine during pregnancy does not increase the risk of miscarriage.

## Contribution

The study provides evidence that specific COVID-19 vaccines are not associated with increased miscarriage risk.

## Key findings

- The cumulative incidence of miscarriage was 10.9% among vaccinated pregnant women.
- Miscarriage rates did not differ significantly across the four vaccine types analyzed.
- The overall miscarriage rate was not higher than expected in the general population.

## Abstract

COVID-19 infection during pregnancy might be associated with maternal complications. This study aimed to investigate the impact of COVID-19 vaccination on the risk of miscarriage. This cohort study included 26,701 women of reproductive age (15–49) who were vaccinated with different vaccines (Sinopharm, Sputnik V, AZD1222 and CoVIran Barekat) between April 2021 and August 2022 in seven cities in Iran. Among them 459 women were pregnant and included in this analysis. All pregnant women were followed up until the end of their pregnancy. The mean age (standard deviation) of pregnant women was 31.7 (6.8) years. Among them, 50 miscarriage cases occurred. The cumulative incidence of miscarriage was 10.9%; 95% confidence intervals [CI] 8.0–13.8) in total, and 11.0% (5.9–16.1), 9.7% (4.4–14.9), 12.0% (5.9–18.2), and 11.1% (4.2–18.0) for AZD1222, Sputnik V, Sinopharm and Barekat vaccines respectively. Cumulative incidence rates by vaccine brands were not statistically significant (P value = 0.962). The mean (SD) time interval between conception and vaccination was 3.5 (3.8) weeks and it was 7.5 (2.7) weeks for the age of the fetus at miscarriage. In general, the miscarriage rate in women of reproductive age was 4.8 (95% CI 4.1–5.7) per 1000 women. The estimated incidence rates were not higher than expected; therefore, it can be argued that COVID − 19 vaccination with Sputnik V, Sinopharm, Barekat and AZD1222 does not increase the probability of miscarriage and the vaccines are therefore safe in this respect.

## Linked entities

- **Diseases:** COVID-19 (MONDO:0100096)

## Full-text entities

- **Diseases:** miscarriage (MESH:D000022), COVID - 19 (MESH:D000086382)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12214967/full.md

---
Source: https://tomesphere.com/paper/PMC12214967